A 40-year-old woman with a 20-year history of systemic lupus erythamatosus (SLE) presents with severe anterior chest pain, dyspnoea and nausea.
Her SLE has manifested previously as arthritis, rash, mucosal ulceration and focal proliferative glomerulonephritis. She has had two miscarriages and delivered two normal children. Treatment has included hydroxychloroquine, prednis(ol)one in doses of 7.5 mg to 100 mg daily, intermittent cyclophosphamide and azathioprine. At presentation she is taking prednis(ol)one 7.5 mg daily and hydroxychloroquine.
Physical examination reveals obesity, pulse rate of 105/minute, blood pressure of 105/75 mmHg, normal heart sounds, and clear lung fields. The jugular venous pulse and pressure are obscured by fat.
Laboratory results show:
haemoglobin 124 g/L [115-165]
white cell count 3.4 x109/L [3.5-11.0]
lymphocytes 0.9 x109/L [1.5 – 4.0]
erythrocyte sedimentation rate (ESR) 35 mm/hr [0-20]
ECG shows ST-segment elevation in the anterior chest leads and sinus tachycardia. During the assessment, the patient develops ventricular fibrillation and dies. Which of the following is the most likely cause of her death?
Select one of the following: